These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 30026680)

  • 1. Contribution of Tau Pathology to Mitochondrial Impairment in Neurodegeneration.
    Pérez MJ; Jara C; Quintanilla RA
    Front Neurosci; 2018; 12():441. PubMed ID: 30026680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial Dysfunction Contributes to the Pathogenesis of Alzheimer's Disease.
    Cabezas-Opazo FA; Vergara-Pulgar K; Pérez MJ; Jara C; Osorio-Fuentealba C; Quintanilla RA
    Oxid Med Cell Longev; 2015; 2015():509654. PubMed ID: 26221414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Truncated Tau Induces Mitochondrial Transport Failure Through the Impairment of TRAK2 Protein and Bioenergetics Decline in Neuronal Cells.
    Quintanilla RA; Tapia-Monsalves C; Vergara EH; Pérez MJ; Aranguiz A
    Front Cell Neurosci; 2020; 14():175. PubMed ID: 32848607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylated tau as a toxic agent in synaptic mitochondria: implications in aging and Alzheimer's disease.
    Torres AK; Rivera BI; Polanco CM; Jara C; Tapia-Rojas C
    Neural Regen Res; 2022 Aug; 17(8):1645-1651. PubMed ID: 35017410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer's disease.
    Chiasseu M; Alarcon-Martinez L; Belforte N; Quintero H; Dotigny F; Destroismaisons L; Vande Velde C; Panayi F; Louis C; Di Polo A
    Mol Neurodegener; 2017 Aug; 12(1):58. PubMed ID: 28774322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau Deletion Prevents Cognitive Impairment and Mitochondrial Dysfunction Age Associated by a Mechanism Dependent on Cyclophilin-D.
    Jara C; Cerpa W; Tapia-Rojas C; Quintanilla RA
    Front Neurosci; 2020; 14():586710. PubMed ID: 33679286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspase-Cleaved Tau Impairs Mitochondrial Dynamics in Alzheimer's Disease.
    Pérez MJ; Vergara-Pulgar K; Jara C; Cabezas-Opazo F; Quintanilla RA
    Mol Neurobiol; 2018 Feb; 55(2):1004-1018. PubMed ID: 28084594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of tau phosphorylation for neurodegenerative diseases.
    Noble W; Hanger DP; Miller CC; Lovestone S
    Front Neurol; 2013; 4():83. PubMed ID: 23847585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease.
    Cai Q; Tammineni P
    J Alzheimers Dis; 2017; 57(4):1087-1103. PubMed ID: 27767992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperphosphorylated Human Tau Accumulates at the Synapse, Localizing on Synaptic Mitochondrial Outer Membranes and Disrupting Respiration in a Mouse Model of Tauopathy.
    Trease AJ; George JW; Roland NJ; Lichter EZ; Emanuel K; Totusek S; Fox HS; Stauch KL
    Front Mol Neurosci; 2022; 15():852368. PubMed ID: 35359570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GSK3β-mediated tau hyperphosphorylation triggers diabetic retinal neurodegeneration by disrupting synaptic and mitochondrial functions.
    Zhu H; Zhang W; Zhao Y; Shu X; Wang W; Wang D; Yang Y; He Z; Wang X; Ying Y
    Mol Neurodegener; 2018 Nov; 13(1):62. PubMed ID: 30466464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Association of Tau With Mitochondrial Dysfunction in Alzheimer's Disease.
    Cheng Y; Bai F
    Front Neurosci; 2018; 12():163. PubMed ID: 29623026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined expression of tau and the Harlequin mouse mutation leads to increased mitochondrial dysfunction, tau pathology and neurodegeneration.
    Kulic L; Wollmer MA; Rhein V; Pagani L; Kuehnle K; Cattepoel S; Tracy J; Eckert A; Nitsch RM
    Neurobiol Aging; 2011 Oct; 32(10):1827-38. PubMed ID: 19942317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.
    Amadoro G; Corsetti V; Stringaro A; Colone M; D'Aguanno S; Meli G; Ciotti M; Sancesario G; Cattaneo A; Bussani R; Mercanti D; Calissano P
    J Alzheimers Dis; 2010; 21(2):445-70. PubMed ID: 20571215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-translational modifications of tau protein.
    Pevalova M; Filipcik P; Novak M; Avila J; Iqbal K
    Bratisl Lek Listy; 2006; 107(9-10):346-53. PubMed ID: 17262986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Untangling the Tauopathy for Alzheimer's disease and parkinsonism.
    Chang HY; Sang TK; Chiang AS
    J Biomed Sci; 2018 Jul; 25(1):54. PubMed ID: 29991349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial traffic jams in Alzheimer's disease - pinpointing the roadblocks.
    Correia SC; Perry G; Moreira PI
    Biochim Biophys Acta; 2016 Oct; 1862(10):1909-17. PubMed ID: 27460705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of neuronal function by soluble hyperphosphorylated tau in a Drosophila model of tauopathy.
    Cowan CM; Chee F; Shepherd D; Mudher A
    Biochem Soc Trans; 2010 Apr; 38(2):564-70. PubMed ID: 20298222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.
    Kamat PK; Kalani A; Rai S; Swarnkar S; Tota S; Nath C; Tyagi N
    Mol Neurobiol; 2016 Jan; 53(1):648-661. PubMed ID: 25511446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AD-linked, toxic NH2 human tau affects the quality control of mitochondria in neurons.
    Amadoro G; Corsetti V; Florenzano F; Atlante A; Ciotti MT; Mongiardi MP; Bussani R; Nicolin V; Nori SL; Campanella M; Calissano P
    Neurobiol Dis; 2014 Feb; 62():489-507. PubMed ID: 24411077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.